Zixin Liang

机构：South China Agricultural University, Nanjing University of Chinese Medicine, Guiyang Medical University, Nanjing Traditional Chinese Medicine Hospital, Nanjing Drum Tower Hospital, Hunan Cancer Hospital

发表论文 10 篇 · 总被引 22 次 · h-index 3

代表论文

• Manganese-based nanoparticles plus gambogic acid targeted hypoxic tumor microenvironment by enhancing ROS generation and provided antitumor treatment and improved immunotherapy (2025 · RSC Advances · 被引 7)
• Evaluation of the anti-tumor effect of gambogic acid loaded macrophage membranes nanoparticles combined with radiotherapy and anti-PD-1mAb in the colorectal cancer with liver metastasis model (2025 · Biomaterials Advances · 被引 4)
• Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCC (2025 · Therapeutic Advances in Medical Oncology · 被引 3)
• VRK2 inhibits the replication of infectious bursal disease virus by phosphorylating RACK1 and suppressing apoptosis (2024 · International Journal of Biological Macromolecules · 被引 3)
• Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer (2025 · OncoImmunology · 被引 2)
• Development and Characterization of Monoclonal Antibodies Against VP3 Protein of Infectious Bursal Disease Virus (2025 · Transboundary and Emerging Diseases · 被引 2)